The molecular characteristics of ischemic stroke with phlegm-heat syndrome and candidate biomarkers were identified based on multi-omics data. The main purpose of this study is to validate the molecular characteristics and biomarkers of phlegm-heat syndrome in ischemic stroke, and to demonstrate the association of biomarkers with clinical outcomes.
Acute ischemic stroke, were confirmed by magnetic resonance imaging (MRI).
Symptom onset within 72 hours.
Diagnosis of phlegm-heat syndrome or non-phlegm-heat syndrome.
Male or female ≥ 50 years and ≤ 80 years.
Planned or already receiving intravenous thrombolysis or endovascular treatment.
Acute infectious diseases or acute exacerbations of chronic diseases within one month before enrollment.
Patients with previous stroke.
Renal or hepatic insufficiency, tumors, immune diseases, severe underlying diseases.
Patients aged 50 to 80 years with acute ischemic stroke within 72 hours of onset. Moreover, these patients fit the diagnosis of phlegm-heat syndrome or non-phlegm-heat syndrome.
Case-control
Other
Not listed
Omic biomarkers associated with phelm-heat syndrome in ischemic stroke
Sensitivity, specificity, and area under the ROC curve of omic biomarkers of Phlegm-heat syndrome in ischemic stroke.
Click on the lead sponsor to view all of their trials.
